EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognosis and Follow‐Up Recommendations for Subcutaneous and Dermal Leiomyosarcoma: Local Recurrence, Metastasis, and Overall Survival in a Danish Nationwide Cohort of 661 Patients

Kiya Abebe, Mathias Ørholt iD, Erik E F Bak, Andreas Larsen, Anne Lene Wagenblast, Grethe Schmidt, David Hebbelstrup Jensen, Michael M Petersen iD, Anand C Loya, Søren Daugaard, Mikkel Herly, Jason L Hornick und 2 weitere

Journal of Surgical Oncology · 2025-11 · 132 (6) · 1076-1085

DOI: 10.1002/jso.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 18.09.2025. Verfasst von Kiya Abebe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery and Burns Treatment, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Leiomyosarcoma, Neoplasm Recurrence, Local, Skin Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This study was funded by the Research Fund of Copenhagen University Hospital Rigshospitalet and the Danish Medical Society..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives The prognostic differences between subcutaneous leiomyosarcoma and dermal leiomyosarcoma are not well defined due to limited cohort sizes and insufficient follow‐up in prior studies. This study aimed to investigate the clinicopathological features of subcutaneous and dermal leiomyosarcoma and estimate their 10‐year rates of metastasis, local recurrence, and overall survival. Additionally, we propose standardized follow‐up recommendations.

Methods

All patients diagnosed with cutaneous leiomyosarcoma in Denmark from 1980 to 2022 were included. The prognosis was estimated using age‐ and sex‐standardized stratified cause‐specific Cox‐regression with all‐cause mortality as competing risk.

Results

We included 196 patients with subcutaneous leiomyosarcoma and 465 with dermal leiomyosarcoma. The 10‐year local recurrence rate was similar in patients with subcutaneous leiomyosarcoma (15%) and dermal leiomyosarcoma (11%, p = 0.13). However, patients with subcutaneous leiomyosarcoma had a significantly higher 10‐year risk of metastasis (25%), primarily observed in grade 2 and 3 tumors, compared with dermal leiomyosarcoma (2.7%), p < 0.001, and a lower 10‐year‐overall survival (56% vs. 64%), p = 0.02.

Conclusions

Grade 2 and 3 subcutaneous leiomyosarcoma should be classified as a high‐risk sarcoma with a substantial risk of metastasis and poor overall survival, necessitating follow‐up that includes both clinical examinations and PET/CT or CT of the thorax for 5 years to detect both locoregional and distant metastases. Dermal leiomyosarcoma should be considered a low‐risk sarcoma due to its low risk of metastasis and moderate risk of local recurrence, suggesting that the follow‐up can focus on clinical examinations for 4 years as the 10‐year risk of local recurrence is < 1% after this time point.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyosarcomaNeoplasm Recurrence, LocalSkin NeoplasmsHumansFemaleMaleDenmarkMiddle AgedAgedPrognosisFollow-Up StudiesSurvival RateAdultAged, 80 and overCohort Studies

Stichwörter der Autor:innen

atypical intradermal smooth muscle neoplasmfollow‐upleiomyosarcomalocal recurrencemetastasisprognosissarcomaskin cancersurvival

Autor:innen und Institutionen

  • Department of Plastic Surgery and Burns Treatment, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Plastic Surgery, Odense University Hospital, Odense, Denmark.
  • Department of Orthopedic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
  • Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Immunology and Microbiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

ORCID-Profile: Mathias Ørholt, Michael M Petersen

Förderung

  • This study was funded by the Research Fund of Copenhagen University Hospital Rigshospitalet and the Danish Medical Society.

Zitieren

APA

Abebe, K., Ørholt, M., Bak, E. E. F., Larsen, A., Wagenblast, A. L., Schmidt, G., Jensen, D. H., Petersen, M. M., Loya, A. C., Daugaard, S., Herly, M., Hornick, J. L., Mentzel, T., & Vester-Glowinski, P. (2025). Prognosis and Follow‐Up Recommendations for Subcutaneous and Dermal Leiomyosarcoma: Local Recurrence, Metastasis, and Overall Survival in a Danish Nationwide Cohort of 661 Patients. Journal of Surgical Oncology, 132(6), 1076-1085. https://doi.org/10.1002/jso.70095

Vancouver

Abebe K, Ørholt M, Bak EEF, Larsen A, Wagenblast AL, Schmidt G, et al. Prognosis and Follow‐Up Recommendations for Subcutaneous and Dermal Leiomyosarcoma: Local Recurrence, Metastasis, and Overall Survival in a Danish Nationwide Cohort of 661 Patients. Journal of Surgical Oncology. 2025;132(6):1076-1085. doi:10.1002/jso.70095

BibTeX
@article{Abebe2025,
  author = {Abebe, Kiya and Ørholt, Mathias and Bak, Erik E F and Larsen, Andreas and Wagenblast, Anne Lene and Schmidt, Grethe and Jensen, David Hebbelstrup and Petersen, Michael M and Loya, Anand C and Daugaard, Søren and Herly, Mikkel and Hornick, Jason L and Mentzel, Thomas and Vester-Glowinski, Peter},
  title = {Prognosis and Follow‐Up Recommendations for Subcutaneous and Dermal Leiomyosarcoma: Local Recurrence, Metastasis, and Overall Survival in a Danish Nationwide Cohort of 661 Patients},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  volume = {132},
  number = {6},
  pages = {1076--1085},
  doi = {10.1002/jso.70095}
}
Kostenlos starten →